For children with cystic fibrosis (CF) who are taking Trikafta (elexacaftor/tezacaftor/ivacaftor), weight gain was associated with decreasing levels of inflammation in the body, a Swiss study reports. The association was seen in both short- and long-term analyses after treatment began. Changes in inflammation and body mass index (BMI),…

Living with cystic fibrosis (CF) made me very aware of breathing. Before my double-lung transplant eight years ago, I’d check the weather before committing to any plans, because protecting my lung health from allergens, weather triggers, and anything that could cause inflammation was essential to my well-being. Since…

Cutting-edge DNA sequencing technologies for microbial surveillance have the potential to revolutionize how lung infections in people with cystic fibrosis (CF) are diagnosed and managed, according to a new review study. However, researchers noted that there are still challenges that need to be overcome before these technologies can be…

Use of Trikafta, an approved oral medication for cystic fibrosis (CF), can reduce airway inflammation — known to exacerbate symptoms — in people with the genetic disease, a new study demonstrates. However, after a year of treatment, CF patients on Trikafta still show differences in airway inflammation compared with…

I turned 55 this month, and I am giddy about it. Not quietly pleased. Not gracefully accepting. Giddy, the way you’re supposed to be at 21 and rarely are, because you don’t yet know what a gift a birthday can be. I know because I’ve spent almost six years breathing…

The Cystic Fibrosis Foundation is funding a new research project that aims to develop a cell-based strategy for rebuilding damaged airway tissue in people with cystic fibrosis (CF). Do-Yeon Cho, MD, a professor in the Department of Otolaryngology–Head and Neck Surgery at the University…